Curcumin, an anti-inflammatory agent, has been used in many chronic inflammatory conditions such as rheumatoid arthritis, esophagitis and post-surgical inflammation. The efficacy of this agent for maintenance of remission in patients with UC has not been systematically evaluated. Objectives The primary objective was to systematically review the efficacy and safety of curcumin for maintenance of remission in UC. 